title: [Complications and side effects of low dose rate brachytherapy for the treatment of prostate cancer: data on a 13 year follow-up study from Mannheim].
abstract: BACKGROUND
  Brachytherapy (BT) is an established treatment option for low risk prostate cancer. The aim of this study was to determine the long-term complications and side effects of the procedure in an up to 13 year long single center follow-up analysis.
  
  
  METHODS
  A total of 505 patients were treated by BT for prostate cancer between May 1991 and August 2005. Cohort I (n=412; May 1991 to November 2003) was evaluated by written questionnaire (modified ICS male) and patient chart evaluation in terms of side effects and secondary interventions. In cohort II (n=148; January 2002 to August 2005) perioperative complications were investigated.
  
  
  RESULTS
  The mean follow-up was 5.5 years. Perioperative complications were present in 5.4% of patients. Transurethral resection of the prostate was a common secondary intervention, performed in 7% of cases. The rate of incontinence was 6.3% in the long-term follow-up, the rate of potency was 43.5% in those patients who were potent before BT and no hormonal manipulation was performed at any time.
  
  
  CONCLUSIONS
  BT is a minimally invasive procedure for the treatment of localised "low risk" prostate cancer. Perioperative complications are rare, secondary intervention may be necessary and the patient has to be informed of possible impotence, incontinence and lack of ejaculation.
authors.affiliation: Urologische Klinik, Universitätsklinikum Mannheim, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. lutz.trojan@uro.ma.uni-heidelberg.de
authors.forename: L
authors.initials: L
authors.lastname: Trojan
authors.forename: K
authors.initials: K
authors.lastname: Harrer
authors.forename: J
authors.initials: J
authors.lastname: Schäfer
authors.forename: M
authors.initials: M
authors.lastname: Voss
authors.forename: G
authors.initials: G
authors.lastname: Welzel
authors.forename: C
authors.initials: C
authors.lastname: Bolenz
authors.forename: F
authors.initials: F
authors.lastname: Wenz
authors.forename: P
authors.initials: P
authors.lastname: Alken
authors.forename: M-S
authors.initials: MS
authors.lastname: Michel
mesh_terms: D000368:Aged; D001918:Brachytherapy / Q000009:adverse effects*; D015331:Cohort Studies; D003131:Combined Modality Therapy; D007172:Erectile Dysfunction / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D011183:Postoperative Complications / Q000209:etiology; D011471:Prostatic Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D011832:Radiation Injuries / Q000209:etiology*; D011879:Radiotherapy Dosage; D012189:Retrospective Studies; D020728:Transurethral Resection of Prostate; D014549:Urinary Incontinence / Q000209:etiology